GENERIC MULTI-STEP THERAPEUTIC TREATMENT PROTOCOL

Patent №

US 6,579,280

Granted

2003-06-17

Filed 1999

Owner

MEDTRONIC INC.

Lab

AI components

1

evo

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

09302613

A generic treatment protocol is disclosed for therapeutically treating a patient via an implantable treatment device. Treatment steps can be defined to start and end at absolute times, or can be programmed via telemetry to start a certain amount of time after termination of a previously executed treatment step. Treatment steps have a treatment rate or dose attribute and a duration attribute. Treatment steps may optionally enable patient-activated bolus overlays. Patient-activated rate or dosage adjustments can also optionally be enabled. Repeated-execution treatment-step groups are also provided. Such treatment-step groups can have start and end times, a group duration, and a group total dose, each defined in a manner similar to that for a treatment step. Treatment-step groups include a repetition count, which could be set to a value that causes the group to repeat forever. Single execution treatment steps can, accordingly, be programmed to execute before and/or after a repeated-execution treatment-step group.

Evolutionary computationA61M 5/14276A61M 5/172G16H 20/17G16H 20/30A61M 2005/14208A61M 2205/3523A61N 1/3605

AI classification

Evolutionary computation0.53
AI hardware0.01
Knowledge representation0.00
Natural language0.00
Speech0.00
Planning0.00
Machine learning0.00
Vision0.00

Ownership

MEDTRONIC INC.

assignment · 102250499

Assignors

KOVACH, PETER J., LANG, CRAIG R., ULLESTAD, DAVID C.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC